OKLAHOMA CITY, Jan. 12, 2021 /PRNewswire-PRWeb/ -- NKD Rehab, LLC, a partnership between Kennor Holdings, Cross Development, and Nobis Rehabilitation Partners, has started the construction phase for the new inpatient rehab hospital at 10240 Broadway Extension, Oklahoma City, OK 73114. The Oklahoma City Rehabilitation Hospital's design is a one-story model with 40 private rooms and a rehab therapy gym with state of the art equipment and technologies.
People with debilitating illnesses and injuries such as stroke, brain injury, and other complex neurological and orthopedic diseases and injuries will be cared for under the management of Nobis Rehabilitation Partners. A medical rehab team of physicians, therapists, and rehab trained nurses will customize each patient's intensive rehab program during their inpatient stay.
"NKD is delighted to develop our first medical rehab hospital in Oklahoma City and we look forward to working with the team at Ridgemont Commercial Construction," said Shane Shoulders, Partner, Kennor Holdings. "This new hospital will bring approximately 120 career opportunities to the OKC area to provide care for patients in our new and modern hospital."
Oklahoma City Rehabilitation Hospital is one of several inpatient rehabilitation hospitals that NKD Rehab and Nobis Rehabilitation Partners has in development to serve patient rehabilitation needs across the country.
About Nobis Rehabilitation Partners
Nobis Rehabilitation Partners brings together healthcare providers, developers, and investment partners to create, operate, and manage inpatient rehabilitation facilities. Patients will receive exceptional care by highly experienced and inspired caregivers in the most uniquely designed and efficient hospital. Visit nobisrehabpartners.com, find them on LinkedIn, follow them on Twitter, and like them on Facebook.
Media Contact
Gina Thomas, Nobis Rehabilitation Partners, +1 4696406507, [email protected]
SOURCE Nobis Rehabilitation Partners
![](https://rt.prnewswire.com/rt.gif?NewsItemId=UN40774&Transmission_Id=202101121000PR_NEWS_USPR_____UN40774&DateId=20210112)
Share this article